Florida SB 816: County Court Judges

Bill Text

816 
Diabetes Research 
2026-03-18T11:05:18Z 
Establishing the University of Florida Diabetes Institute within the University of Florida College of Medicine; authorizing the institute to administer statewide pilot programs; requiring the institute to maintain a secure repository for deidentified data; authorizing the institute to share deidentified data under certain conditions; authorizing the institute to convene a consortium, etc. 
ENROLLED 
2026 
S 
2026-07-01T00:00:00Z 
GB 
General Bill 
er 

 ENROLLED 
 2026 Legislature SB 816 

 2026816er 
 1 
 2 An act relating to diabetes research; creating s. 
 3 1004.562, F.S.; establishing the University of Florida 
 4 Diabetes Institute within the University of Florida 
 5 College of Medicine; providing the purpose of the 
 6 institute; providing requirements for the institute; 
 7 authorizing the institute to administer statewide 
 8 pilot programs; requiring the institute to maintain a 
 9 secure repository for deidentified data; authorizing 
 10 the institute to share deidentified data under certain 
 11 conditions; authorizing the institute to convene a 
 12 consortium; providing requirements for the consortium; 
 13 authorizing the consortium to solicit funding from 
 14 certain sources for certain purposes; requiring the 
 15 institute to provide a report to the Governor and the 
 16 Legislature beginning on a specified date and annually 
 17 thereafter; providing requirements for the report; 
 18 providing construction; providing an effective date. 
 19 
 20 Be It Enacted by the Legislature of the State of Florida: 
 21 
 22 Section 1. Section 1004.562, Florida Statutes, is created 
 23 to read: 
 24 1004.562 University of Florida Diabetes Institute.— 
 25 (1) The University of Florida Diabetes Institute is 
 26 established within the University of Florida College of Medicine 
 27 as a resource for diabetes research, screening, prevention, 
 28 treatment, and education. The purpose of the institute is to 
 29 advance scientific discovery, improve prevention and clinical 
 30 care, and promote education and outreach related to all forms of 
 31 diabetes, including type 1 diabetes, type 2 diabetes, 
 32 gestational diabetes, and related metabolic conditions. 
 33 (2) The institute shall do all of the following: 
 34 (a) Conduct research to understand the causes, mechanisms, 
 35 and potential cures for diabetes, including autoimmune, genetic, 
 36 and environmental factors. 
 37 (b) Develop advanced prevention, diagnostic, and treatment 
 38 strategies to reduce the incidence and complications of diabetes 
 39 in children and adults. 
 40 (c) Provide comprehensive, multidisciplinary clinical care 
 41 to individuals living with diabetes, including patient and 
 42 family education, nutrition counseling, mental health support, 
 43 and disease management resources. 
 44 (d) Train and educate health care professionals, including 
 45 physicians, nurses, dietitians, pharmacists, and scientists, to 
 46 expand expertise in diabetes care and research. 
 47 (e) Establish collaborations with state universities, 
 48 medical centers, patient advocacy groups, community 
 49 organizations, and government agencies to enhance care and 
 50 accelerate progress toward diabetes prevention and cures. 
 51 (f) Engage in community-based outreach and education 
 52 programs to increase awareness, reduce disparities in diabetes 
 53 outcomes, and promote healthier lifestyles. 
 54 (3)(a) The institute may establish and administer statewide 
 55 pilot programs, including, but not limited to, population-based 
 56 diabetes screening, prevention initiatives, and technology 
 57 driven management tools. 
 58 (b) The institute shall maintain a secure data repository 
 59 to collect, store, and analyze deidentified data for the purpose 
 60 of advancing diabetes research, prevention, and care. 
 61 (c) The institute may provide deidentified data, pursuant 
 62 to data-sharing agreements, to research collaborators to support 
 63 ongoing and future scientific investigations. 
 64 (4)(a) The institute may convene a statewide diabetes 
 65 research and care consortium composed of clinical and academic 
 66 experts, health care providers, and patient representatives to 
 67 coordinate research, share expertise, and develop innovative 
 68 care models. 
 69 (b) The consortium shall, upon being convened, be 
 70 administered at the institute under the direction of the 
 71 institute’s executive leadership. 
 72 (c) The consortium may solicit funding from public, 
 73 nonprofit, and private sources to expand programs, research 
 74 initiatives, and community services. 
 75 (5) Beginning October 15, 2027, and annually thereafter, 
 76 the institute shall provide a report to the Governor, the 
 77 President of the Senate, and the Speaker of the House of 
 78 Representatives which includes all of the following: 
 79 (a) Research projects and findings. 
 80 (b) Clinical services provided and